Literature DB >> 8202900

Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs.

M R Lang1, G W Fiaux, M Gillooly, J A Stewart, D J Hulmes, D Lamb.   

Abstract

BACKGROUND: Emphysema is currently defined as "a condition of the lung characterised by abnormal, permanent enlargement of the airspaces distal to the terminal bronchiole, accompanied by destruction of their walls, and without obvious fibrosis." The functional and morphological changes that occur in emphysema have largely been attributed to changes in alveolar elastin rather than in collagen. A study was performed to determine whether the amount of collagen in the alveolar wall changes with age in the lungs of non-smokers and of smokers with different types of macroscopically defined emphysema in relation to a microscopic measurement of lung structure.
METHODS: Total alveolar wall collagen was measured (as hydroxyproline) in known volumes of distended lung tissue (by reverse phase high pressure liquid chromatography) in the lungs of non-smokers (n = 23) and in regions sampled away from emphysematous lesions in the lungs of 36 smokers (four with no emphysema, 13 with centriacinar emphysema (CAE), nine with panacinar emphysema (PAE), and 10 with a mixture (MIX) of both PAE and CAE). Mean lung airspace wall surface area per unit volume (AWUV) was calculated from at least six random blocks per lung and on histological sections immediately adjacent to those prepared for collagen measurement with a rapid scanning device (fast interval processor).
RESULTS: In non-smokers there was no significant correlation between the amount of collagen in the alveolar wall tissue and either mean lung AWUV or increasing patient age when amounts of collagen were expressed either per unit volume of distended lung (40 mm3 sample) or per unit surface area of airspace wall tissue. Smokers without emphysema had similar amounts of collagen to non-smokers. Lungs with PAE and MIX, but not CAE alone, contained significantly more collagen than normal when expressed per unit volume of airspace wall tissue whereas all groups, including CAE, contained significantly raised amounts of collagen when expressed per unit surface area.
CONCLUSIONS: There is no significant age related change in the collagen content of the lungs of non-smokers which suggests that, as AWUV is lost with age, the main collagenous framework is maintained. However, in smokers with emphysema there is a loss of airspace wall tissue in regions remote from the macroscopic lesions that is accompanied by a net increase in collagen mass. The greater accumulation of collagen in MIX lungs than in CAE lungs suggests a greater degree of structural damage, indicative of an alternative pathogenetic mechanism operating between the different types of emphysema. Our results suggest an active alveolar wall fibrosis in emphysema as a consequence of cigarette smoking. It is suggested that the definition of emphysema may require further revision to include such change.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202900      PMCID: PMC475363          DOI: 10.1136/thx.49.4.319

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Mechanical properties of lungs.

Authors:  J MEAD
Journal:  Physiol Rev       Date:  1961-04       Impact factor: 37.312

Review 2.  Lung collagen: more than scaffolding.

Authors:  G J Laurent
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

3.  The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1985-07

4.  Organization of collagen in the human pulmonary alveolar wall.

Authors:  T H Rosenquist
Journal:  Anat Rec       Date:  1981-08

5.  Elastin content of normal and emphysematous lung parenchyma.

Authors:  P Chrzanowski; S Keller; J Cerreta; I Mandl; G M Turino
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

6.  Collagen polymorphism in idiopathic chronic pulmonary fibrosis.

Authors:  J M Seyer; E T Hutcheson; A H Kang
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

Review 7.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis.

Authors:  A Janoff
Journal:  Am Rev Respir Dis       Date:  1985-08

8.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis.

Authors:  J M Kirk; P E Da Costa; M Turner-Warwick; R J Littleton; G J Laurent
Journal:  Clin Sci (Lond)       Date:  1986-01       Impact factor: 6.124

10.  Biochemical and histological changes in pulmonary fibrosis induced in rabbits with intratracheal bleomycin.

Authors:  G J Laurent; R J McAnulty; B Corrin; P Cockerill
Journal:  Eur J Clin Invest       Date:  1981-12       Impact factor: 4.686

View more
  48 in total

Review 1.  Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.

Authors:  J C Hogg; R M Senior
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

2.  Alteration of fibroblast architecture and loss of Basal lamina apertures in human emphysematous lung.

Authors:  Faye E Sirianni; Alireza Milaninezhad; Fanny S F Chu; David C Walker
Journal:  Am J Respir Crit Care Med       Date:  2006-01-13       Impact factor: 21.405

Review 3.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

4.  Biochemical and morphological alterations in lungs induced by experimental inhibition of fibrinolytic activity.

Authors:  Izzet Hoşgör; Aysen Yarat; Nukhet Tüzüner; Faruk Alkan; Nesrin Emekli; Sarfraz Ahmad
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

Review 5.  Smad3 signaling involved in pulmonary fibrosis and emphysema.

Authors:  Jack Gauldie; Martin Kolb; Kjetil Ask; Gail Martin; Philippe Bonniaud; David Warburton
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 6.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

7.  Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype.

Authors:  Lennart K A Lundblad; John Thompson-Figueroa; Timothy Leclair; Michael J Sullivan; Matthew E Poynter; Charles G Irvin; Jason H T Bates
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

Review 8.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

9.  Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.

Authors:  Carlos H Martinez; Alejandro A Diaz; Catherine Meldrum; Jeffrey L Curtis; Christopher B Cooper; Cheryl Pirozzi; Richard E Kanner; Robert Paine; Prescott G Woodruff; Eugene R Bleecker; Nadia N Hansel; R Graham Barr; Nathaniel Marchetti; Gerard J Criner; Ella A Kazerooni; Eric A Hoffman; Brian D Ross; Craig J Galban; Christine T Cigolle; Fernando J Martinez; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

10.  Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype.

Authors:  Seyed Javad Moghaddam; Cecilia G Clement; M Miguelina De la Garza; Xiaoyan Zou; Elizabeth L Travis; Hays W J Young; Christopher M Evans; Michael J Tuvim; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.